In the Margins

Carlyle: Travelers CEO steps off board to fight illness

October 28, 2015

By Bloomberg

Carlyle Group LP said Travelers Cos. CEO Jay Fishman stepped down from its board while fighting amyotrophic lateral sclerosis, or ALS. Fishman, 62, said in August he would be replaced as Travelers CEO on Dec. 1 by Alan Schnitzer and stay on as executive chairman. Anthony Welters, executive chairman of investment company Black Ivy Group and a senior adviser to the office of the CEO at UnitedHealth Group Inc., has joined the Carlyle board as independent director. Read the original story from Bloomberg.

 

 

Most Read

Top of the Agenda - Compensation
IDC: Directors see modest pay increase in 2021

Independent mutual fund director compensation levels increased in 2021, though the year-on-year change was significantly lower than in 2020, according to new data obtained by Fund Board ...

Top of the Agenda - Regulatory
SEC to advisers: Turn over 15(c) documents, info

The Securities and Exchange Commission has begun requesting documentation and information from mutual fund advisers about their funds' 15(c) processes and fees. The Division of Enforcement ...